Learn more

GREENPHARMA SAS

Overview
  • Total Patents
    63
  • GoodIP Patent Rank
    67,611
  • Filing trend
    0.0%
About

GREENPHARMA SAS has a total of 63 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2002. It filed its patents most often in France, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are INTEGRA MEDICAL INC, TECH EGON and DENOVASTELLA AB.

Patent filings per year

Chart showing GREENPHARMA SASs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Bernard Philippe 59
#2 Himbert Franck 13
#3 Do Quoc Tuan 11
#4 Trovero Fabrice 11
#5 Abboud Dayana 7
#6 Galzi Jean-Luc 7
#7 Frossard Nelly 7
#8 Pillard Christelle 7
#9 Raboisson Pierre 6
#10 Bernard Francois-Xavier 6

Latest patents

Publication Filing date Title
WO2016198756A1 Cosmetic, nutraceutical, veterinary and pharmaceutical compositions containing a hazelnut pericarp extract
EP3197460A1 Dermocosmetic or pharmaceutical use of a composition containing at least one inhibitor of certain chemokines
US2017112737A1 Cosmetics and pharmaceutical applications of gallic acid and gallic acid derivatives
FR3031455A1 GALLIC ACID DERIVATIVE AND APPLICATIONS
FR3026105A1 COMPOSITION COMPRISING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES, METHOD FOR PRODUCING THE SAME, AND DERMOCOSMETIC OR PHARMACEUTICAL USE THEREOF
FR3018685A1 COSMETIC AND PHARMACEUTICAL APPLICATIONS OF SALICARIA
FR3017296A1 Pharmaceutical composition for the treatment of dependence in human beings
UA111364C2 Pharmaceutical composition for treating dependency in human beings
CN102711746A Pharmaceutical composition for treating alcohol dependency
BRPI0807207A2 COMPOUND INHIBITING METAL-ECTOPEPTIDASE, COMPOSITION CONTAINING COMPOUND, USE OF COMPOUND AND COSMETIC TREATMENT PROCESS OF HUMAN SKIN OR MUCOSA MEMBRANE
CN101141946A Use of silymarine and/or the constituents thereof as promoters of the pigmentation of the skin or hair
WO2006018538A1 Medicament for the treatment of central nervous system disorders
EP1761507A1 Phosphodiesterase-inhibiting compounds of the 2,3-benzodiazepine type
WO2005039523A1 Composition comprising a sesquiterpene lactone
AU2003273473A8 Novel substituted pyrazolo(1,5 less thanigreater thanaless than/igreater than)-1,3,5-triazine derivatives and their analogues, pharmaceutical compositions containing same, use thereof as medicine and methods for preparing same